CDK6 and breast cancer: For instance, increased expression levels of CDK4, CDK6, cyclin D1, cyclin E1 and cyclin E2 along with a reduction of RB1 copy number were found associated with the resistance to palbociclib in ER-positive BC cells models [33, 36, 102, 103].